ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Alpha Cognition (ACOG)
Alpha Cognition stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · NASDAQ
$8.94▲ +7.65%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
48%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Alpha Cognition in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Alpha Cognition
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Alpha Cognition a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $8.11 and $9.74; in 9 out of 10, between $6.90 and $11.45. Estimated annual volatility is 38%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $198M
- 52-week high
- $10.14
- 52-week low
- $4.50
- Revenue (12 months)
- $15.3M
- Gross margin
- 81.3%
- Operating margin
- -220.9%
- Net margin
- -202.2%
- Return on equity
- -49.5%
- Free cash flow (12 months)
- $-28.5M
- Beta
- 2.24
What this means
ATLAS does not publish a fair value for ACOG right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks ACOG has traded between $4.50 and $10.14. Today it is 11.9% below that high and 99% above its low.
Its beta is 2.24: it tends to move more than the market, both up and down.
About the company
Alpha Cognition Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for neurodegenerative diseases, with an emphasis on Alzheimer’s disease and cognitive impairment linked to mild traumatic brain injury.
Want to see everything about Alpha Cognition?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Alpha Cognition do?
Alpha Cognition Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for neurodegenerative diseases, with an emphasis on Alzheimer’s disease and cognitive impairment linked to mild traumatic brain injury.
What is the chance ACOG goes up next month?
48%: close to a coin flip. In half of the simulated outcomes, ACOG ends the month between $8.11 and $9.74.
How big is Alpha Cognition and what is its P/E ratio?
Alpha Cognition's market capitalization is $198M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is ACOG?
ATLAS estimates annual volatility at 38%. In a typical month, half of the outcomes end between $8.11 and $9.74.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer